$230.57
$0.00 (0.00%)
End-of-day quote: 05/17/2024
NasdaqGS:BIIB
Biogen Competitors
| Ticker | Name | Exchange | Consensus | Price | Price Target | Upside/Downside | Analysts | Market Cap |
|---|---|---|---|---|---|---|---|---|
| LLY | Eli Lilly and | NYSE | Outperform | $770.00 | $636.99 | 0.00% | 9 | $693.31B |
| NOVO B | Novo Nordisk A/S | CPSE | Outperform | kr903.30 | kr696.07 | 0.00% | 14 | kr4.01T |
| JNJ | Johnson & Johnson | NYSE | Outperform | $154.64 | $174.55 | 0.00% | 3 | $372.17B |
| MRK | Merck | NYSE | Outperform | $131.19 | $130.51 | 0.00% | 11 | $332.28B |
| ABBV | AbbVie | NYSE | Outperform | $166.42 | $178.42 | 0.00% | 11 | $293.88B |
| AZN | AstraZeneca PLC | LSE | Outperform | £121.10 | £165.99 | 0.00% | 16 | £187.73B |
| ROG | Roche Holding | SWX | Hold | CHF237.10 | CHF307.83 | 0.00% | 9 | CHF191.28B |
| NOVN | Novartis | SWX | Hold | CHF93.37 | CHF105.00 | 0.00% | 9 | CHF190.51B |
| DHR | Danaher | NYSE | Outperform | $265.80 | $260.33 | 0.00% | 4 | $196.87B |
| AMGN | Amgen | NasdaqGS | Outperform | $312.47 | $303.65 | 0.00% | 8 | $167.62B |
| PFE | Pfizer | NYSE | Outperform | $28.64 | $32.87 | 0.00% | 6 | $162.29B |
| SAN | Sanofi | ENXTPA | Outperform | 89.17€ | 102.80€ | 0.00% | 9 | 111.47€B |
| VRTX | Vertex Pharmaceuticals Inc | NASDAQ | Outperform | $445.21 | $457.59 | 0.00% | 11 | $114.89B |
| MDT | Medtronic | NYSE | Outperform | $85.92 | $92.47 | 0.00% | 9 | $114.09B |
| REGN | Regeneron Pharmaceuticals | NasdaqGS | Outperform | $982.29 | $961.26 | 0.00% | 8 | $105.97B |
| GSK | GSK | LSE | Outperform | £17.75 | £17.30 | 0.00% | 12 | £72.39B |
| CSL | CSL | ASX | Outperform | $280.00 | $205.51 | 0.00% | 5 | $135.31B |
| BMY | Bristol-Myers Squibb | NYSE | Hold | $44.03 | $58.15 | 0.00% | 10 | $89.25B |
| GILD | Gilead Sciences Inc | NASDAQ | Outperform | $67.72 | $87.82 | 0.00% | 14 | $84.36B |
| ZTS | Zoetis | NYSE | Outperform | $174.06 | $220.47 | 0.00% | 5 | $79.42B |
| MRK | Merck KGaA | XTRA | Outperform | 167.20€ | 190.06€ | 0.00% | 4 | 72.69€B |
| MRNA | Moderna | NasdaqGS | Outperform | $132.90 | $135.42 | 0.00% | 1 | $50.93B |
| 4502 | Takeda Pharmaceutical Company | TSE | Outperform | ¥4.13k | ¥4.74k | 0.00% | 0 | ¥6.48T |
| DSFIR | DSM-Firmenich | ENXTAM | Outperform | 107.45€ | 114.60€ | 0.00% | 0 | 28.50€B |
| BAYN | Bayer | XTRA | Hold | 28.58€ | 45.15€ | 0.00% | 4 | 28.08€B |
| DIM | Sartorius Stedim Biotech | ENXTPA | Outperform | 196.80€ | 254.69€ | 0.00% | 3 | 19.15€B |
| GMAB | Genmab A/S | CPSE | Outperform | kr2.04k | kr2.71k | 0.00% | 14 | kr131.83B |
| ALNY | Alnylam Pharmaceuticals Inc | NASDAQ | Outperform | $149.40 | $245.24 | 0.00% | 7 | $18.90B |
| TEVA | Teva Pharmaceutical Industries | NYSE | Outperform | $16.29 | $11.59 | 0.00% | 9 | $18.45B |
| CE | Celanese | NYSE | Hold | $157.34 | $148.23 | 0.00% | 18 | $17.18B |
| 4503 | Astellas Pharma | TSE | Outperform | ¥1.49k | ¥2.64k | 0.00% | 0 | ¥2.67T |
| SY1 | Symrise | XTRA | Outperform | 102.40€ | 106.97€ | 0.00% | 5 | 14.31€B |
| BMRN | BioMarin Pharmaceutical | NasdaqGS | Outperform | $77.56 | $111.56 | 0.00% | 5 | $14.62B |
| 4523 | Eisai | TSE | Outperform | ¥6.78k | ¥9.58k | 0.00% | 0 | ¥1.97T |
| SRPT | Sarepta Therapeutics | NasdaqGS | Outperform | $131.38 | $158.66 | 0.00% | 6 | $12.51B |
| UTHR | United Therapeutics | NasdaqGS | Outperform | $274.26 | $284.08 | 0.00% | 3 | $11.80B |
| 500124 | Dr. Reddy's Laboratories | BSE | Hold | Rp5.80k | Rp5.67k | 0.00% | 25 | Rp977.65B |
| SOBI | Swedish Orphan Biovitrum AB (p... | OM | Outperform | kr277.00 | kr293.00 | 0.00% | 6 | kr96.39B |
| CRDA | Croda International Plc | LSE | Outperform | £47.08 | £65.12 | 0.00% | 6 | £6.81B |
| GRF | Grifols | BME | Outperform | 9.89€ | 18.48€ | 0.00% | 3 | 5.85€B |
| IONS | Ionis Pharmaceuticals | NasdaqGS | Outperform | $37.31 | $55.60 | 0.00% | 3 | $5.76B |
| WCH | Wacker Chemie | XTRA | Outperform | 103.15€ | 145.36€ | 0.00% | 9 | 5.00€B |
| CLN | Clariant | SWX | Outperform | CHF14.42 | CHF16.11 | 0.00% | 6 | CHF4.67B |
| BIOCON | Biocon | NSEI | Hold | Rp305.85 | Rp270.86 | 0.00% | 14 | Rp365.06B |
| PRGO | Perrigo Co PLC | NYSE | Outperform | $29.83 | $44.75 | 0.00% | 0 | $4.19B |
| ALKS | Alkermes | NasdaqGS | Outperform | $24.15 | $33.27 | 0.00% | 3 | $4.11B |
| 4403 | NOF | TSE | Buy | ¥2.06k | ¥7.63k | 0.00% | 0 | ¥505.28B |
| TGTX | TG Therapeutics | NasdaqCM | Outperform | $16.48 | $29.44 | 0.00% | 6 | $2.38B |
| DYN | Dyne Therapeutics | NasdaqGS | Buy | $27.68 | $28.13 | 0.00% | 0 | $2.27B |
| DCPH | Deciphera Pharmaceuticals | NasdaqGS | Hold | $25.46 | $23.40 | 0.00% | 4 | $2.19B |
| 4516 | Nippon Shinyaku | TSE | Outperform | ¥3.70k | ¥8.34k | 0.00% | 0 | ¥261.33B |
| WVE | Wave Life Sciences | NasdaqGM | Outperform | $6.26 | $9.21 | 0.00% | 3 | $688.23M |
| STOK | Stoke Therapeutics | NasdaqGS | Buy | $13.90 | $19.33 | 0.00% | 3 | $604.59M |
| ABUS | Arbutus Biopharma | NasdaqGS | Outperform | $2.98 | $6.34 | 0.00% | 0 | $535.96M |
| FULC | Fulcrum Therapeutics | NasdaqGM | Outperform | $7.55 | $10.21 | 0.00% | 7 | $456.83M |
| AMRN | Amarin | NasdaqGM | Hold | $0.87 | $2.05 | 0.00% | 1 | $378.19M |
| NKTR | Nektar Therapeutics | NasdaqCM | Hold | $1.76 | $2.75 | 0.00% | 2 | $301.14M |
| CHRS | Coherus BioSciences | NasdaqGM | Outperform | $2.12 | $10.86 | 0.00% | 3 | $255.37M |
| PYC | PYC Therapeutics | ASX | Buy | $0.10 | $0.30 | 0.00% | 1 | $294.90M |
| MTNB | Matinas BioPharma Holdings | NYSEAM | Buy | $0.17 | $0.65 | 0.00% | 0 | $44.04M |
| ACST | Acasti Pharma | NasdaqCM | Buy | $2.69 | $16.34 | 0.00% | 0 | $26.98M |
| 542934 | Chandra Bhagat Pharma | BSE | - | Rp114.60 | Rp0.00 | 0.00% | 0 | Rp866.55M |
| ENZN | Enzon Pharmaceuticals | OTCPK | - | $0.09 | $16.00 | 0.00% | 0 | $8.48M |
| ACOR | Acorda Therapeutics | NasdaqGS | - | $0.43 | $200.00 | 0.00% | 1 | $0.53M |
| NPHC | Nutra Pharma | OTCPK | - | $0.00 | $0.53 | 0.00% | 0 | $0.01M |
| CDXI | Cardax | OTCPK | - | $0.00 | $0.00 | 0.00% | 0 | $0.00M |
